Marinus Pharmaceuticals - A Biopharmaceutical Company Focused on Innovative Therapeutics

Hey, this is Stocks_Pedia.

I'd like to introduce some unfamiliar companies that may be helpful to your investment.

The company I am going to introduce is $Marinus Pharmaceuticals(MRNS)$

It went public on July 31th, 2014 .

【Company Profile】

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders.

It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.

【History & Events】

In 2014: Stifel Healthcare Conference

In 2016: Future Leaders in the Biotech Industry Conference

In 2017: American Academy of Neurology Medical Conference

In 2018: Jefferies 2018 Global Healthcare Conference

In 2019: Update on ganaxolone for treatment of RSE KOL Meeting at AES

In 2020: Oppenheimer Virtual Fireside Chat: Hot Topics in Epilepsy with KOL and Marinus Pharmaceuticals (MRNS) Management

In 2021: Marinus Pharmaceuticals Virtual Investor Event at American Epilepsy Society 2021 Annual Meeting

In 2022: 16th EILAT Conference on New Antiepileptic Drugs and Devices

【Main bussness segments】

【Net Income & Total Revenue】

【Competitors】

Intarcia Therapeutics

CureVac $CureVac B.V.(CVAC)$

Alembic Pharmaceuticals

EMS Pharma

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

bwjx
2022-06-15
bwjx
OK. will check out this company on morningstar too.
CYberviRus
2022-06-15
CYberviRus
Thank you
ArcherWG
2022-06-15
ArcherWG
OK noted
0xV4mp
2022-06-15
0xV4mp
Good report
JoelLee
2022-06-15
JoelLee
Da sh da Bhss s
Semangkaka
2022-06-19
Semangkaka
Yep

Leave a comment

147

1

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":9055249618,"tweetId":"9055249618","gmtCreate":1655282318327,"gmtModify":1676535603968,"author":{"id":3479274794225176,"authorId":3479274794225176,"authorIdStr":"3479274794225176","name":"Stocks_Pedia","avatar":"https://community-static.tradeup.com/news/59e1332ef20049fa9607ec1058f5a3ea","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":775,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://community-static.tradeup.com/news/056aa867e4f6c9455636a0d600d2f0f3","width":"-1","height":"-1"},{"img":"https://community-static.tradeup.com/news/276a7e43254a804b3776d2cc377030ca","width":"-1","height":"-1"},{"img":"https://community-static.tradeup.com/news/0cd6107a51f08d2136265be6846ee0fc","width":"-1","height":"-1"},{"img":"https://community-static.tradeup.com/news/07d94ea99d3de9097a505efc97058446","width":"-1","height":"-1"},{"img":"https://community-static.tradeup.com/news/b1cef541f4a0e1714b8b560895845fdf","width":"-1","height":"-1"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/056aa867e4f6c9455636a0d600d2f0f3","width":"-1","height":"-1"},{"img":"https://community-static.tradeup.com/news/276a7e43254a804b3776d2cc377030ca","width":"-1","height":"-1"},{"img":"https://community-static.tradeup.com/news/0cd6107a51f08d2136265be6846ee0fc","width":"-1","height":"-1"}],"title":"Marinus Pharmaceuticals - A Biopharmaceutical Company Focused on Innovative Therapeutics","extraTitle":"","html":"<html><head></head><body><p>Hey, this is Stocks_Pedia.</p><p>I'd like to introduce some unfamiliar companies that may be helpful to your investment. </p><p>The company I am&nbsp;going to introduce is&nbsp;<a href=\"https://laohu8.com/S/MRNS\">$Marinus Pharmaceuticals(MRNS)$</a> </p><p>It went&nbsp;public on&nbsp;July&nbsp;31th,&nbsp;2014&nbsp;.</p><p><img src=\"https://community-static.tradeup.com/news/276a7e43254a804b3776d2cc377030ca\" tg-width=\"-1\" tg-height=\"-1\"></p><h2>【Company&nbsp;Profile】</h2><p>Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders.</p><p> It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.</p><h2>【History&nbsp;&amp;&nbsp;Events】</h2><p><b>In&nbsp;2014:</b>&nbsp;&nbsp;Stifel Healthcare Conference</p><p><b>In&nbsp;2016:</b>&nbsp;Future Leaders in the Biotech Industry Conference</p><p><b>In&nbsp;2017:</b>&nbsp;American Academy of Neurology Medical Conference</p><p><b>In&nbsp;2018:</b>&nbsp;Jefferies 2018 Global Healthcare Conference</p><p><b>In&nbsp;2019:</b>&nbsp;Update on ganaxolone for treatment of RSE KOL Meeting at AES</p><p><b>In&nbsp;2020:</b>&nbsp;Oppenheimer Virtual Fireside Chat: Hot Topics in Epilepsy with KOL and Marinus Pharmaceuticals (MRNS) Management</p><p><b>In&nbsp;2021:</b>&nbsp;&nbsp;Marinus Pharmaceuticals Virtual Investor Event at American Epilepsy Society 2021 Annual Meeting</p><p><b>In&nbsp;2022:</b>&nbsp;&nbsp;16th EILAT Conference on New Antiepileptic Drugs and Devices</p><h2>【Main&nbsp;bussness&nbsp;segments】</h2><h2><img src=\"https://community-static.tradeup.com/news/b1cef541f4a0e1714b8b560895845fdf\" tg-width=\"-1\" tg-height=\"-1\"></h2><h2>【Net&nbsp;Income&nbsp;&amp;&nbsp;Total&nbsp;Revenue】</h2><h2><img src=\"https://community-static.tradeup.com/news/0cd6107a51f08d2136265be6846ee0fc\" tg-width=\"-1\" tg-height=\"-1\"><img src=\"https://community-static.tradeup.com/news/07d94ea99d3de9097a505efc97058446\" tg-width=\"-1\" tg-height=\"-1\"></h2><h2>【Competitors】</h2><p>Intarcia Therapeutics&nbsp;</p><p>CureVac&nbsp;<a href=\"https://laohu8.com/S/CVAC\">$CureVac B.V.(CVAC)$</a> </p><p>Alembic Pharmaceuticals&nbsp;</p><p>EMS Pharma&nbsp;<img src=\"https://community-static.tradeup.com/news/056aa867e4f6c9455636a0d600d2f0f3\" tg-width=\"-1\" tg-height=\"-1\"></p></body></html>","htmlText":"<html><head></head><body><p>Hey, this is Stocks_Pedia.</p><p>I'd like to introduce some unfamiliar companies that may be helpful to your investment. </p><p>The company I am&nbsp;going to introduce is&nbsp;<a href=\"https://laohu8.com/S/MRNS\">$Marinus Pharmaceuticals(MRNS)$</a> </p><p>It went&nbsp;public on&nbsp;July&nbsp;31th,&nbsp;2014&nbsp;.</p><p><img src=\"https://community-static.tradeup.com/news/276a7e43254a804b3776d2cc377030ca\" tg-width=\"-1\" tg-height=\"-1\"></p><h2>【Company&nbsp;Profile】</h2><p>Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders.</p><p> It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.</p><h2>【History&nbsp;&amp;&nbsp;Events】</h2><p><b>In&nbsp;2014:</b>&nbsp;&nbsp;Stifel Healthcare Conference</p><p><b>In&nbsp;2016:</b>&nbsp;Future Leaders in the Biotech Industry Conference</p><p><b>In&nbsp;2017:</b>&nbsp;American Academy of Neurology Medical Conference</p><p><b>In&nbsp;2018:</b>&nbsp;Jefferies 2018 Global Healthcare Conference</p><p><b>In&nbsp;2019:</b>&nbsp;Update on ganaxolone for treatment of RSE KOL Meeting at AES</p><p><b>In&nbsp;2020:</b>&nbsp;Oppenheimer Virtual Fireside Chat: Hot Topics in Epilepsy with KOL and Marinus Pharmaceuticals (MRNS) Management</p><p><b>In&nbsp;2021:</b>&nbsp;&nbsp;Marinus Pharmaceuticals Virtual Investor Event at American Epilepsy Society 2021 Annual Meeting</p><p><b>In&nbsp;2022:</b>&nbsp;&nbsp;16th EILAT Conference on New Antiepileptic Drugs and Devices</p><h2>【Main&nbsp;bussness&nbsp;segments】</h2><h2><img src=\"https://community-static.tradeup.com/news/b1cef541f4a0e1714b8b560895845fdf\" tg-width=\"-1\" tg-height=\"-1\"></h2><h2>【Net&nbsp;Income&nbsp;&amp;&nbsp;Total&nbsp;Revenue】</h2><h2><img src=\"https://community-static.tradeup.com/news/0cd6107a51f08d2136265be6846ee0fc\" tg-width=\"-1\" tg-height=\"-1\"><img src=\"https://community-static.tradeup.com/news/07d94ea99d3de9097a505efc97058446\" tg-width=\"-1\" tg-height=\"-1\"></h2><h2>【Competitors】</h2><p>Intarcia Therapeutics&nbsp;</p><p>CureVac&nbsp;<a href=\"https://laohu8.com/S/CVAC\">$CureVac B.V.(CVAC)$</a> </p><p>Alembic Pharmaceuticals&nbsp;</p><p>EMS Pharma&nbsp;<img src=\"https://community-static.tradeup.com/news/056aa867e4f6c9455636a0d600d2f0f3\" tg-width=\"-1\" tg-height=\"-1\"></p></body></html>","text":"Hey, this is Stocks_Pedia. I'd like to introduce some unfamiliar companies that may be helpful to your investment. The company I am going to introduce is $Marinus Pharmaceuticals(MRNS)$ It went public on July 31th, 2014 . 【Company Profile】 Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania. 【History & Events】 In 2014: Stifel Healthcare Conference In 2016: Future Leaders in the Biotech Industry Conference In 2017: American Academy of Neurology Medical Conference In 2018: Jefferies 2018 Global Healthcare Conference In 2019: Update on ganaxolone for treatment of RSE KOL Meeting at AES In 2020: Oppenheimer Virtual Fireside Chat: Hot Topics in Epilepsy with KOL and Marinus Pharmaceuticals (MRNS) Management In 2021: Marinus Pharmaceuticals Virtual Investor Event at American Epilepsy Society 2021 Annual Meeting In 2022: 16th EILAT Conference on New Antiepileptic Drugs and Devices 【Main bussness segments】 【Net Income & Total Revenue】 【Competitors】 Intarcia Therapeutics CureVac $CureVac B.V.(CVAC)$ Alembic Pharmaceuticals EMS Pharma","highlighted":2,"essential":1,"paper":2,"likeSize":147,"commentSize":0,"repostSize":1,"favoriteSize":0,"link":"https://ttm.financial/post/9055249618","repostId":0,"isVote":1,"tweetType":1,"viewCount":2500,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["MRNS","CVAC"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":1212,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":102350957,"gmtCreate":1655289492533,"gmtModify":1663251928452,"authorId":3583219343417269,"author":{"id":3583219343417269,"authorId":3583219343417269,"name":"bwjx","avatar":"https://community-static.tradeup.com/news/8caef76a71a3e44507b696f3580a8fd7","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9055249618,"type":1,"supId":0,"prevId":0,"content":"OK. will check out this company on morningstar too.","text":"OK. will check out this company on morningstar too.","html":"OK. will check out this company on morningstar too.","likeSize":3,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":102350931,"gmtCreate":1655289389889,"gmtModify":1663251929932,"authorId":4099364351782360,"author":{"id":4099364351782360,"authorId":4099364351782360,"name":"CYberviRus","avatar":"https://community-static.tradeup.com/news/01a9dd052e60cc14e090e6a5b7323791","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.01","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.01","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"repliedAuthorId":0,"objectId":9055249618,"type":1,"supId":0,"prevId":0,"content":"<u>Thank you</u>","text":"<u>Thank you</u>","html":"<u>Thank you</u>","likeSize":3,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":102350215,"gmtCreate":1655286472553,"gmtModify":1663251928436,"authorId":3581837121803380,"author":{"id":3581837121803380,"authorId":3581837121803380,"name":"ArcherWG","avatar":"https://community-static.tradeup.com/news/38e40c44fababa6849ceb15dfe8931a3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9055249618,"type":1,"supId":0,"prevId":0,"content":"OK <u>noted</u>","text":"OK <u>noted</u>","html":"OK <u>noted</u>","likeSize":3,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":102350885,"gmtCreate":1655289215899,"gmtModify":1663251929937,"authorId":4113870911596752,"author":{"id":4113870911596752,"authorId":4113870911596752,"name":"0xV4mp","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9055249618,"type":1,"supId":0,"prevId":0,"content":"Good <u>report</u>","text":"Good <u>report</u>","html":"Good <u>report</u>","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":102349592,"gmtCreate":1655282912046,"gmtModify":1663251923743,"authorId":3579882572140125,"author":{"id":3579882572140125,"authorId":3579882572140125,"name":"JoelLee","avatar":"https://static.tigerbbs.com/e1f6c92b13d94cba61906c07dbbb2ab6","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.08","exceedPercentage":"80.98%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":1,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9055249618,"type":1,"supId":0,"prevId":0,"content":"Da sh da Bhss s","text":"Da sh da Bhss s","html":"Da sh da Bhss s","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":102429735,"gmtCreate":1655630029528,"gmtModify":1663252278252,"authorId":3562484784257058,"author":{"id":3562484784257058,"authorId":3562484784257058,"name":"Semangkaka","avatar":"https://static.tigerbbs.com/f90131e92acdf55a1c46162e05bd5cd1","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9055249618,"type":1,"supId":0,"prevId":0,"content":"Yep","text":"Yep","html":"Yep","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/9055249618"}